US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclacel Pharmaceuticals

8.24

+0.41505.31%

Post-market: 8.00-0.2350-2.85%19:50 EDT

Volume:97.37K

Turnover:807.55K

Market Cap:18.44M

PE:-0.85

High:8.82

Open:7.78

Low:7.74

Close:7.82

52wk High:597.60

52wk Low:3.08

Shares:2.24M

Float Shares:966.60K

Volume Ratio:2.04

T/O Rate:10.07%

Dividend:0.00

Dividend Rate:0.01%

EPS(TTM):-9.6620

EPS(LYR):-502.4648

ROE:-276.80%

ROA:-102.83%

PB:5.08

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Cyclacel Pharmaceuticals Dismisses Bush & Associates, Appoints SFAI as New Auditor Amid Financial Concerns

Cyclacel Pharmaceuticals Q2 EPS $(0.98) Up From $(10.80) YoY

Cyclacel Pharmaceuticals Reports Zero Revenue, Operating Loss of $5.04M for Q1 2025

David E. Lazar, 10% Owner, Reports Disposal of Common Shares of Cyclacel Pharmaceuticals Inc

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

Cyclacel Pharmaceuticals Removes Series F Ownership Limitation in Bylaws Amendment

Cyclacel Pharmaceuticals trading halted, volatility trading pause

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

Cyclacel Pharmaceuticals Secures $3 Million in Series F Preferred Stock Sale

Cyclacel announces amendment to exchange agreement with Fitters

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT

Cyclacel Pharmaceuticals trading halted, news pending

Cyclacel Pharmaceuticals Announces 1-for-15 Reverse Stock Split Effective July 7, 2025

Cyclacel Pharmaceuticals Inc. Concluded Annual Shareholder Meeting

Cyclacel Pharmaceuticals Secures $3 Million Through Preferred Stock Agreement with Investors

Press Release: Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

Cyclacel Pharmaceuticals Inc. Declares Quarterly Cash Dividend of $0.15 Per Share on Preferred Stock

Cyclacel Pharmaceuticals Regains Nasdaq Compliance After Meeting Minimum Bid Price Requirement

Cyclacel Pharmaceuticals Approves Reverse Stock Split Amendment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CYCC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CYCC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYCC\",,,,,undefined,":{"symbol":"CYCC","market":"US","secType":"STK","nameCN":"Cyclacel Pharmaceuticals","latestPrice":8.235,"timestamp":1756497600000,"preClose":7.82,"halted":0,"volume":97365,"hourTrading":{"tag":"盘后","latestPrice":8,"preClose":8.235,"latestTime":"19:50 EDT","volume":728,"amount":5854.74,"timestamp":1756511437028},"delay":0,"floatShares":966600,"shares":2238984,"eps":-9.661975,"marketStatus":"Market Closed","change":0.415,"latestTime":"08-29 16:00:00 EDT","open":7.78,"high":8.82,"low":7.74,"amount":807545.1152700001,"amplitude":0.138107,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.661975,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1079413200000,"exchange":"NASDAQ","adjPreClose":7.82,"dividendRate":0.000121,"preHourTrading":{"tag":"盘前","latestPrice":7.82,"preClose":7.82,"latestTime":"09:29 EDT","volume":903,"amount":6960.751119,"timestamp":1756474169974},"postHourTrading":{"tag":"盘后","latestPrice":8,"preClose":8.235,"latestTime":"19:50 EDT","volume":728,"amount":5854.74,"timestamp":1756511437028},"volumeRatio":2.042736650167621,"impliedVol":6.1603,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYCC\",,,,,undefined,":{"symbol":"CYCC","floatShares":966600,"roa":"-102.83%","roe":"-276.80%","lyrEps":-502.46482,"volumeRatio":2.042736650167621,"shares":2238984,"dividePrice":0.001,"high":8.82,"amplitude":0.138107,"preClose":7.82,"low":7.74,"week52Low":3.0801,"pbRate":"5.08","psRate":"1843.80","week52High":597.6,"institutionHeld":0.0019,"latestPrice":8.235,"eps":-9.661975,"divideRate":0.000121,"volume":97365,"delay":0,"ttmEps":-9.661975,"open":7.78,"prevYearClose":90.24,"prevWeekClose":7.99,"prevMonthClose":11.21,"prevQuarterClose":4.9545,"fiveDayClose":7.99,"twentyDayClose":9.72,"sixtyDayClose":21.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CYCC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-13","symbol":"CYCC","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.98},{"market":"US","date":"2025-07-07","symbol":"CYCC","type":"split","dateTimestamp":1751860800000,"forFactor":15,"toFactor":1,"ratio":15},{"date":"2025-05-15","symbol":"CYCC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1747296000000,"name":null,"time":"Pre-Market","dateTimestamp":1747281600000,"actualEps":null},{"market":"US","date":"2025-05-12","symbol":"CYCC","defaultRemindTime":1747056600000,"type":"split","dateTimestamp":1747022400000,"forFactor":16,"toFactor":1,"ratio":16},{"market":"US","date":"2025-04-02","symbol":"CYCC","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743566400000,"reportTimeType":"post","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CYCC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CYCC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CYCC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CYCC","date":"2025-08-29","current":-2.732343,"percent":0.24065,"low":-9.169306,"twenty":-3.581732,"median":-0.742766,"eighty":-0.15986,"high":-0.046237,"avg":-1.814028,"sd":2.082928,"marketCap":17508854},"quantilePoints":[{"date":"2020-09-04","current":-2.104886,"twenty":-2.250927,"median":-1.403927,"eighty":-0.920779,"marketCap":15978187},{"date":"2020-09-11","current":-2.120905,"twenty":-2.250927,"median":-1.414725,"eighty":-0.920779,"marketCap":16099787},{"date":"2020-09-18","current":-2.39643,"twenty":-2.257316,"median":-1.418607,"eighty":-0.920779,"marketCap":18191300},{"date":"2020-09-25","current":-2.197795,"twenty":-2.257316,"median":-1.423637,"eighty":-0.920779,"marketCap":16683465},{"date":"2020-10-02","current":-2.351577,"twenty":-2.271424,"median":-1.432744,"eighty":-0.922129,"marketCap":17850821},{"date":"2020-10-09","current":-2.524581,"twenty":-2.280702,"median":-1.436295,"eighty":-0.922129,"marketCap":19164096},{"date":"2020-10-16","current":-2.492543,"twenty":-2.291507,"median":-1.44383,"eighty":-0.922129,"marketCap":18920897},{"date":"2020-10-23","current":-2.415653,"twenty":-2.297876,"median":-1.447904,"eighty":-0.922129,"marketCap":18337219},{"date":"2020-10-30","current":-2.088867,"twenty":-2.297876,"median":-1.45161,"eighty":-0.922129,"marketCap":15856587},{"date":"2020-11-06","current":-2.095274,"twenty":-2.297876,"median":-1.457521,"eighty":-0.922129,"marketCap":15905227},{"date":"2020-11-13","current":-2.16694,"twenty":-2.297876,"median":-1.468134,"eighty":-0.922129,"marketCap":17218503},{"date":"2020-11-20","current":-2.099605,"twenty":-2.297876,"median":-1.472881,"eighty":-0.922129,"marketCap":16683465},{"date":"2020-11-27","current":-2.3567,"twenty":-2.299641,"median":-1.47521,"eighty":-0.922129,"marketCap":18726338},{"date":"2020-12-04","current":-2.552582,"twenty":-2.312759,"median":-1.48105,"eighty":-0.922129,"marketCap":20282813},{"date":"2020-12-11","current":-2.644401,"twenty":-2.328798,"median":-1.487866,"eighty":-0.922129,"marketCap":21012410},{"date":"2020-12-18","current":-2.589309,"twenty":-2.328807,"median":-1.498709,"eighty":-0.922129,"marketCap":20574652},{"date":"2020-12-24","current":-4.909282,"twenty":-2.337501,"median":-1.503145,"eighty":-0.922129,"marketCap":39009151},{"date":"2020-12-31","current":-4.780734,"twenty":-2.343131,"median":-1.508869,"eighty":-0.922129,"marketCap":37987715},{"date":"2021-01-08","current":-5.423471,"twenty":-2.345314,"median":-1.522105,"eighty":-0.926982,"marketCap":43094898},{"date":"2021-01-15","current":-4.499155,"twenty":-2.354816,"median":-1.52525,"eighty":-0.935686,"marketCap":35750282},{"date":"2021-01-22","current":-4.548125,"twenty":-2.356324,"median":-1.527771,"eighty":-0.938958,"marketCap":36139401},{"date":"2021-01-29","current":-4.303273,"twenty":-2.361831,"median":-1.531041,"eighty":-0.950117,"marketCap":34193807},{"date":"2021-02-05","current":-5.398985,"twenty":-2.37213,"median":-1.53716,"eighty":-0.963145,"marketCap":42900338},{"date":"2021-02-12","current":-5.582624,"twenty":-2.38429,"median":-1.545134,"eighty":-0.981163,"marketCap":44359534},{"date":"2021-02-19","current":-5.209225,"twenty":-2.391612,"median":-1.551306,"eighty":-0.988457,"marketCap":41392503},{"date":"2021-02-26","current":-4.223696,"twenty":-2.398858,"median":-1.556021,"eighty":-0.996609,"marketCap":33561489},{"date":"2021-03-05","current":-5.189996,"twenty":-2.410526,"median":-1.556804,"eighty":-1.020434,"marketCap":43829520},{"date":"2021-03-12","current":-7.966428,"twenty":-2.417449,"median":-1.560215,"eighty":-1.028247,"marketCap":67276487},{"date":"2021-03-19","current":-9.122065,"twenty":-2.424075,"median":-1.569857,"eighty":-1.036129,"marketCap":77035838},{"date":"2021-03-26","current":-8.045683,"twenty":-2.43017,"median":-1.574882,"eighty":-1.050095,"marketCap":67945793},{"date":"2021-04-01","current":-8.132663,"twenty":-2.444412,"median":-1.584312,"eighty":-1.054404,"marketCap":68680342},{"date":"2021-04-09","current":-8.045683,"twenty":-2.455678,"median":-1.588442,"eighty":-1.060063,"marketCap":67945793},{"date":"2021-04-16","current":-7.088899,"twenty":-2.460929,"median":-1.594504,"eighty":-1.067223,"marketCap":59865753},{"date":"2021-04-23","current":-7.43682,"twenty":-2.476019,"median":-1.604,"eighty":-1.070469,"marketCap":62803949},{"date":"2021-04-30","current":-7.774366,"twenty":-2.477445,"median":-1.610439,"eighty":-1.078513,"marketCap":65654522},{"date":"2021-05-07","current":-7.315121,"twenty":-2.492543,"median":-1.620401,"eighty":-1.091994,"marketCap":61776195},{"date":"2021-05-14","current":-5.858134,"twenty":-2.493334,"median":-1.626962,"eighty":-1.094691,"marketCap":62699606},{"date":"2021-05-21","current":-6.6605,"twenty":-2.50049,"median":-1.640187,"eighty":-1.102647,"marketCap":71287329},{"date":"2021-05-28","current":-6.185982,"twenty":-2.511264,"median":-1.641783,"eighty":-1.108673,"marketCap":66208568},{"date":"2021-06-04","current":-5.832251,"twenty":-2.524897,"median":-1.651528,"eighty":-1.117165,"marketCap":62422583},{"date":"2021-06-11","current":-6.056568,"twenty":-2.552985,"median":-1.657219,"eighty":-1.134115,"marketCap":64823452},{"date":"2021-06-18","current":-5.374989,"twenty":-2.567893,"median":-1.662305,"eighty":-1.149322,"marketCap":57528505},{"date":"2021-06-25","current":-5.651072,"twenty":-2.582625,"median":-1.663446,"eighty":-1.156705,"marketCap":60483420},{"date":"2021-07-02","current":-4.97812,"twenty":-2.595928,"median":-1.668611,"eighty":-1.164048,"marketCap":53280814},{"date":"2021-07-09","current":-5.004002,"twenty":-2.611591,"median":-1.670844,"eighty":-1.171569,"marketCap":53557838},{"date":"2021-07-16","current":-4.469092,"twenty":-2.616689,"median":-1.680502,"eighty":-1.17958,"marketCap":47832689},{"date":"2021-07-23","current":-4.736547,"twenty":-2.629002,"median":-1.686617,"eighty":-1.186116,"marketCap":50695263},{"date":"2021-07-30","current":-4.279285,"twenty":-2.646308,"median":-1.687388,"eighty":-1.192573,"marketCap":45801185},{"date":"2021-08-06","current":-4.382816,"twenty":-2.661694,"median":-1.694508,"eighty":-1.194425,"marketCap":46909278},{"date":"2021-08-13","current":-3.311412,"twenty":-2.687141,"median":-1.699818,"eighty":-1.199378,"marketCap":45247139},{"date":"2021-08-20","current":-3.095157,"twenty":-2.704641,"median":-1.714305,"eighty":-1.200235,"marketCap":42292223},{"date":"2021-08-27","current":-3.642554,"twenty":-2.715712,"median":-1.723432,"eighty":-1.206328,"marketCap":49771852},{"date":"2021-09-03","current":-4.068307,"twenty":-2.735742,"median":-1.739914,"eighty":-1.21162,"marketCap":55589342},{"date":"2021-09-10","current":-3.791229,"twenty":-2.757817,"median":-1.746428,"eighty":-1.21547,"marketCap":51803357},{"date":"2021-09-17","current":-3.872325,"twenty":-2.788273,"median":-1.755796,"eighty":-1.218229,"marketCap":52911450},{"date":"2021-09-24","current":-3.649312,"twenty":-2.858001,"median":-1.767424,"eighty":-1.223121,"marketCap":49864194},{"date":"2021-10-01","current":-3.669586,"twenty":-2.961308,"median":-1.77837,"eighty":-1.226832,"marketCap":50141217},{"date":"2021-10-08","current":-3.581732,"twenty":-2.996369,"median":-1.782351,"eighty":-1.229411,"marketCap":48940783},{"date":"2021-10-15","current":-3.764197,"twenty":-3.016597,"median":-1.806057,"eighty":-1.232949,"marketCap":51433992},{"date":"2021-10-22","current":-3.399266,"twenty":-3.052332,"median":-1.822951,"eighty":-1.23656,"marketCap":46447573},{"date":"2021-10-29","current":-3.31817,"twenty":-3.077279,"median":-1.838934,"eighty":-1.238334,"marketCap":45339480},{"date":"2021-11-05","current":-3.35196,"twenty":-3.103109,"median":-1.854347,"eighty":-1.253293,"marketCap":45801185},{"date":"2021-11-12","current":-2.968754,"twenty":-3.120431,"median":-1.876656,"eighty":-1.258468,"marketCap":48678658},{"date":"2021-11-19","current":-2.561159,"twenty":-3.120431,"median":-1.903376,"eighty":-1.267417,"marketCap":41995318},{"date":"2021-11-26","current":-2.342152,"twenty":-3.120431,"median":-1.914377,"eighty":-1.276942,"marketCap":38404269},{"date":"2021-12-03","current":-1.971058,"twenty":-3.120431,"median":-1.958832,"eighty":-1.282896,"marketCap":32319437},{"date":"2021-12-10","current":-2.16573,"twenty":-3.120431,"median":-1.989276,"eighty":-1.30441,"marketCap":35511480},{"date":"2021-12-17","current":-2.056227,"twenty":-3.120431,"median":-2.029161,"eighty":-1.312229,"marketCap":33715956},{"date":"2021-12-23","current":-2.433405,"twenty":-3.120431,"median":-2.04406,"eighty":-1.322548,"marketCap":39900540},{"date":"2021-12-31","current":-2.366486,"twenty":-3.120431,"median":-2.076052,"eighty":-1.323344,"marketCap":38803275},{"date":"2022-01-07","current":-2.378653,"twenty":-3.117734,"median":-2.08765,"eighty":-1.32361,"marketCap":39002777},{"date":"2022-01-14","current":-2.202231,"twenty":-3.117734,"median":-2.099547,"eighty":-1.32361,"marketCap":36109988},{"date":"2022-01-21","current":-1.904139,"twenty":-3.117734,"median":-2.099861,"eighty":-1.32361,"marketCap":31222172},{"date":"2022-01-28","current":-1.873722,"twenty":-3.117734,"median":-2.099861,"eighty":-1.327453,"marketCap":30723415},{"date":"2022-02-04","current":-1.977141,"twenty":-3.117734,"median":-2.099861,"eighty":-1.329912,"marketCap":32419188},{"date":"2022-02-11","current":-2.080561,"twenty":-3.117734,"median":-2.103284,"eighty":-1.337669,"marketCap":34114961},{"date":"2022-02-18","current":-2.044121,"twenty":-3.117734,"median":-2.11578,"eighty":-1.337669,"marketCap":33517451},{"date":"2022-02-25","current":-2.037977,"twenty":-3.117734,"median":-2.11578,"eighty":-1.34244,"marketCap":33416702},{"date":"2022-03-04","current":-2.129229,"twenty":-3.117734,"median":-2.117062,"eighty":-1.34841,"marketCap":34912972},{"date":"2022-03-11","current":-1.788553,"twenty":-3.117734,"median":-2.117062,"eighty":-1.381976,"marketCap":29326896},{"date":"2022-03-18","current":-1.861555,"twenty":-3.117734,"median":-2.117062,"eighty":-1.386631,"marketCap":30523913},{"date":"2022-03-25","current":-1.94064,"twenty":-3.117734,"median":-2.117062,"eighty":-1.399234,"marketCap":31820680},{"date":"2022-04-01","current":-1.645505,"twenty":-3.117734,"median":-2.117062,"eighty":-1.400476,"marketCap":31078649},{"date":"2022-04-08","current":-1.497356,"twenty":-3.117734,"median":-2.11578,"eighty":-1.400476,"marketCap":28280572},{"date":"2022-04-14","current":-1.084657,"twenty":-3.117734,"median":-2.11578,"eighty":-1.400077,"marketCap":20485926},{"date":"2022-04-22","current":-1.031747,"twenty":-3.117734,"median":-2.11578,"eighty":-1.392727,"marketCap":19486613},{"date":"2022-04-29","current":-0.989419,"twenty":-3.117734,"median":-2.11578,"eighty":-1.382576,"marketCap":18687162},{"date":"2022-05-06","current":-0.925927,"twenty":-3.117734,"median":-2.11578,"eighty":-1.35496,"marketCap":17487986},{"date":"2022-05-13","current":-0.711843,"twenty":-3.117734,"median":-2.11578,"eighty":-1.347049,"marketCap":13893034},{"date":"2022-05-20","current":-0.706722,"twenty":-3.117734,"median":-2.11578,"eighty":-1.329651,"marketCap":13793084},{"date":"2022-05-27","current":-0.619662,"twenty":-3.117734,"median":-2.11578,"eighty":-1.31277,"marketCap":12093936},{"date":"2022-06-03","current":-0.609419,"twenty":-3.117734,"median":-2.11578,"eighty":-1.309949,"marketCap":11894036},{"date":"2022-06-10","current":-0.619662,"twenty":-3.117734,"median":-2.11578,"eighty":-1.29119,"marketCap":12093936},{"date":"2022-06-17","current":-0.665752,"twenty":-3.117734,"median":-2.11578,"eighty":-1.276942,"marketCap":12993485},{"date":"2022-06-24","current":-0.706722,"twenty":-3.120431,"median":-2.117062,"eighty":-1.267417,"marketCap":13793084},{"date":"2022-07-01","current":-0.56845,"twenty":-3.120431,"median":-2.117062,"eighty":-1.256895,"marketCap":11094437},{"date":"2022-07-08","current":-0.599177,"twenty":-3.120431,"median":-2.117062,"eighty":-1.253489,"marketCap":11694137},{"date":"2022-07-15","current":-0.624783,"twenty":-3.120431,"median":-2.117062,"eighty":-1.24937,"marketCap":12193886},{"date":"2022-07-22","current":-0.675995,"twenty":-3.120431,"median":-2.117062,"eighty":-1.24937,"marketCap":13193385},{"date":"2022-07-29","current":-0.583813,"twenty":-3.120431,"median":-2.117062,"eighty":-1.24937,"marketCap":11394287},{"date":"2022-08-05","current":-0.599177,"twenty":-3.120431,"median":-2.117062,"eighty":-1.24937,"marketCap":11694137},{"date":"2022-08-12","current":-1.024822,"twenty":-3.120431,"median":-2.117062,"eighty":-1.24306,"marketCap":19435742},{"date":"2022-08-19","current":-1.031433,"twenty":-3.120431,"median":-2.117062,"eighty":-1.237884,"marketCap":19561134},{"date":"2022-08-26","current":-1.104163,"twenty":-3.120431,"median":-2.117062,"eighty":-1.234418,"marketCap":20940445},{"date":"2022-09-02","current":-1.117386,"twenty":-3.120431,"median":-2.117062,"eighty":-1.229886,"marketCap":21191229},{"date":"2022-09-09","current":-1.110774,"twenty":-3.120431,"median":-2.117062,"eighty":-1.226126,"marketCap":21065837},{"date":"2022-09-16","current":-0.991763,"twenty":-3.120431,"median":-2.117062,"eighty":-1.216315,"marketCap":18808783},{"date":"2022-09-23","current":-0.813246,"twenty":-3.120431,"median":-2.117062,"eighty":-1.213136,"marketCap":15423202},{"date":"2022-09-30","current":-0.965316,"twenty":-3.120431,"median":-2.117062,"eighty":-1.206328,"marketCap":18307215},{"date":"2022-10-07","current":-0.846304,"twenty":-3.120431,"median":-2.117062,"eighty":-1.195588,"marketCap":16050161},{"date":"2022-10-14","current":-0.859528,"twenty":-3.120431,"median":-2.117062,"eighty":-1.193674,"marketCap":16300945},{"date":"2022-10-21","current":-0.79341,"twenty":-3.120431,"median":-2.117062,"eighty":-1.17446,"marketCap":15047026},{"date":"2022-10-28","current":-0.938869,"twenty":-3.120431,"median":-2.117062,"eighty":-1.16493,"marketCap":17805648},{"date":"2022-11-04","current":-0.75374,"twenty":-3.120431,"median":-2.117062,"eighty":-1.149597,"marketCap":14294675},{"date":"2022-11-11","current":-0.775769,"twenty":-3.120431,"median":-2.117062,"eighty":-1.121744,"marketCap":14796243},{"date":"2022-11-18","current":-0.598328,"twenty":-3.120431,"median":-2.117062,"eighty":-1.110774,"marketCap":11411915},{"date":"2022-11-25","current":-0.549613,"twenty":-3.120431,"median":-2.117062,"eighty":-1.103522,"marketCap":10482762},{"date":"2022-12-02","current":-0.571965,"twenty":-3.120431,"median":-2.117062,"eighty":-1.084327,"marketCap":10909094},{"date":"2022-12-09","current":-0.467499,"twenty":-3.120431,"median":-2.117062,"eighty":-1.070002,"marketCap":8916617},{"date":"2022-12-16","current":-0.502146,"twenty":-3.120431,"median":-2.117062,"eighty":-1.060493,"marketCap":9577432},{"date":"2022-12-23","current":-0.482423,"twenty":-3.120431,"median":-2.117062,"eighty":-1.054404,"marketCap":9201256},{"date":"2022-12-30","current":-0.438507,"twenty":-3.120431,"median":-2.117062,"eighty":-1.051269,"marketCap":8363639},{"date":"2023-01-06","current":-0.49761,"twenty":-3.120431,"median":-2.101682,"eighty":-1.044657,"marketCap":9490912},{"date":"2023-01-13","current":-0.631135,"twenty":-3.120431,"median":-2.098812,"eighty":-1.034949,"marketCap":12037633},{"date":"2023-01-20","current":-0.644283,"twenty":-3.120431,"median":-2.088867,"eighty":-1.026291,"marketCap":12288405},{"date":"2023-01-27","current":-0.57854,"twenty":-3.120431,"median":-2.076834,"eighty":-1.018027,"marketCap":11034486},{"date":"2023-02-03","current":-0.696877,"twenty":-3.120431,"median":-2.056227,"eighty":-0.999093,"marketCap":13291540},{"date":"2023-02-10","current":-0.677089,"twenty":-3.120431,"median":-2.04406,"eighty":-0.980464,"marketCap":12914110},{"date":"2023-02-17","current":-0.723174,"twenty":-3.120431,"median":-2.031893,"eighty":-0.963245,"marketCap":13793107},{"date":"2023-02-24","current":-0.606809,"twenty":-3.120431,"median":-2.019726,"eighty":-0.948526,"marketCap":11573671},{"date":"2023-03-03","current":-0.506222,"twenty":-3.120431,"median":-2.002965,"eighty":-0.93672,"marketCap":9655175},{"date":"2023-03-10","current":-0.386267,"twenty":-3.120431,"median":-1.977141,"eighty":-0.929726,"marketCap":8188090},{"date":"2023-03-17","current":-0.385616,"twenty":-3.120431,"median":-1.961043,"eighty":-0.916424,"marketCap":8174297},{"date":"2023-03-24","current":-0.35468,"twenty":-3.120431,"median":-1.946724,"eighty":-0.90581,"marketCap":7518497},{"date":"2023-03-31","current":-0.337466,"twenty":-3.117734,"median":-1.937599,"eighty":-0.892515,"marketCap":7153607},{"date":"2023-04-06","current":-0.337407,"twenty":-3.117734,"median":-1.907181,"eighty":-0.892114,"marketCap":7152353},{"date":"2023-04-14","current":-0.342553,"twenty":-3.120431,"median":-1.861555,"eighty":-0.881957,"marketCap":7261444},{"date":"2023-04-21","current":-0.41259,"twenty":-3.120431,"median":-1.824204,"eighty":-0.878027,"marketCap":8746084},{"date":"2023-04-28","current":-0.343145,"twenty":-3.120431,"median":-1.755796,"eighty":-0.871664,"marketCap":7273983},{"date":"2023-05-05","current":-0.305169,"twenty":-3.120431,"median":-1.741211,"eighty":-0.86688,"marketCap":6468967},{"date":"2023-05-12","current":-0.305237,"twenty":-3.120431,"median":-1.721634,"eighty":-0.848676,"marketCap":6988090},{"date":"2023-05-19","current":-0.329829,"twenty":-3.120431,"median":-1.705919,"eighty":-0.846246,"marketCap":7551099},{"date":"2023-05-26","current":-0.366963,"twenty":-3.120431,"median":-1.69262,"eighty":-0.836829,"marketCap":8401256},{"date":"2023-06-02","current":-0.358364,"twenty":-3.120431,"median":-1.687388,"eighty":-0.833081,"marketCap":8204391},{"date":"2023-06-09","current":-0.372386,"twenty":-3.120431,"median":-1.678951,"eighty":-0.828551,"marketCap":8525394},{"date":"2023-06-16","current":-0.363704,"twenty":-3.120431,"median":-1.663446,"eighty":-0.822458,"marketCap":8326648},{"date":"2023-06-23","current":-0.36647,"twenty":-3.123128,"median":-1.662448,"eighty":-0.81296,"marketCap":8389971},{"date":"2023-06-30","current":-0.322818,"twenty":-3.125825,"median":-1.652027,"eighty":-0.80678,"marketCap":7390597},{"date":"2023-07-07","current":-0.317615,"twenty":-3.125825,"median":-1.641783,"eighty":-0.802368,"marketCap":7271475},{"date":"2023-07-14","current":-0.328624,"twenty":-3.125825,"median":-1.640187,"eighty":-0.794461,"marketCap":7523513},{"date":"2023-07-21","current":-0.383394,"twenty":-3.128522,"median":-1.625652,"eighty":-0.79278,"marketCap":8777432},{"date":"2023-07-28","current":-0.355187,"twenty":-3.128522,"median":-1.600502,"eighty":-0.777779,"marketCap":8131651},{"date":"2023-08-04","current":-0.336839,"twenty":-3.128522,"median":-1.585712,"eighty":-0.762981,"marketCap":7711601},{"date":"2023-08-11","current":-0.290173,"twenty":-3.128522,"median":-1.557586,"eighty":-0.75374,"marketCap":6896553},{"date":"2023-08-18","current":-0.228738,"twenty":-3.128522,"median":-1.539429,"eighty":-0.746869,"marketCap":5436413},{"date":"2023-08-25","current":-0.239377,"twenty":-3.128522,"median":-1.527616,"eighty":-0.727206,"marketCap":5689269},{"date":"2023-09-01","current":-0.210652,"twenty":-3.128522,"median":-1.524792,"eighty":-0.716964,"marketCap":5006557},{"date":"2023-09-08","current":-0.179026,"twenty":-3.128522,"median":-1.51217,"eighty":-0.711843,"marketCap":4254914},{"date":"2023-09-15","current":-0.15154,"twenty":-3.128522,"median":-1.500382,"eighty":-0.70094,"marketCap":3601659},{"date":"2023-09-22","current":-0.175867,"twenty":-3.128522,"median":-1.487582,"eighty":-0.691358,"marketCap":4179827},{"date":"2023-09-29","current":-0.181132,"twenty":-3.128522,"median":-1.47521,"eighty":-0.688657,"marketCap":4304972},{"date":"2023-10-06","current":-0.19219,"twenty":-3.128522,"median":-1.470081,"eighty":-0.675869,"marketCap":4567775},{"date":"2023-10-13","current":-0.237473,"twenty":-3.128522,"median":-1.450957,"eighty":-0.664006,"marketCap":5644018},{"date":"2023-10-20","current":-0.338043,"twenty":-3.128522,"median":-1.4436,"eighty":-0.644283,"marketCap":8034279},{"date":"2023-10-27","current":-0.289917,"twenty":-3.128522,"median":-1.435254,"eighty":-0.637073,"marketCap":6890458},{"date":"2023-11-03","current":-0.308142,"twenty":-3.128522,"median":-1.422144,"eighty":-0.624678,"marketCap":7323621},{"date":"2023-11-10","current":-0.305345,"twenty":-3.128522,"median":-1.417578,"eighty":-0.62028,"marketCap":7257131},{"date":"2023-11-17","current":-0.179168,"twenty":-3.128522,"median":-1.404778,"eighty":-0.615208,"marketCap":4437630},{"date":"2023-11-24","current":-0.15778,"twenty":-3.128522,"median":-1.400532,"eighty":-0.609419,"marketCap":3907896},{"date":"2023-12-01","current":-0.153538,"twenty":-3.128522,"median":-1.399902,"eighty":-0.599177,"marketCap":3792846},{"date":"2023-12-08","current":-0.138184,"twenty":-3.128522,"median":-1.387254,"eighty":-0.594134,"marketCap":3413561},{"date":"2023-12-15","current":-0.126413,"twenty":-3.128522,"median":-1.382576,"eighty":-0.587507,"marketCap":3122777},{"date":"2023-12-22","current":-0.12283,"twenty":-3.128522,"median":-1.382576,"eighty":-0.578692,"marketCap":3034278},{"date":"2023-12-29","current":-0.117186,"twenty":-3.128522,"median":-1.382576,"eighty":-0.573571,"marketCap":2894840},{"date":"2024-01-05","current":-0.093835,"twenty":-3.128522,"median":-1.382576,"eighty":-0.571913,"marketCap":2318012},{"date":"2024-01-12","current":-0.11471,"twenty":-3.128522,"median":-1.382576,"eighty":-0.564353,"marketCap":2833681},{"date":"2024-01-19","current":-0.085414,"twenty":-3.128522,"median":-1.382576,"eighty":-0.553086,"marketCap":2109971},{"date":"2024-01-26","current":-0.110998,"twenty":-3.128522,"median":-1.382576,"eighty":-0.533111,"marketCap":2741974},{"date":"2024-02-02","current":-0.117401,"twenty":-3.128522,"median":-1.368165,"eighty":-0.506485,"marketCap":2900165},{"date":"2024-02-09","current":-0.123805,"twenty":-3.128522,"median":-1.334265,"eighty":-0.502304,"marketCap":3058356},{"date":"2024-02-16","current":-0.142216,"twenty":-3.128522,"median":-1.312267,"eighty":-0.48763,"marketCap":3513154},{"date":"2024-02-23","current":-0.140348,"twenty":-3.128522,"median":-1.284305,"eighty":-0.479951,"marketCap":3467015},{"date":"2024-03-01","current":-0.136612,"twenty":-3.128522,"median":-1.269495,"eighty":-0.459413,"marketCap":3374737},{"date":"2024-03-08","current":-0.132877,"twenty":-3.128522,"median":-1.255568,"eighty":-0.435904,"marketCap":3282459},{"date":"2024-03-15","current":-0.133192,"twenty":-3.128522,"median":-1.237884,"eighty":-0.420114,"marketCap":3290237},{"date":"2024-03-22","current":-0.127413,"twenty":-3.128522,"median":-1.234986,"eighty":-0.395102,"marketCap":2873800},{"date":"2024-03-28","current":-0.114555,"twenty":-3.128522,"median":-1.231337,"eighty":-0.387309,"marketCap":2583783},{"date":"2024-04-05","current":-0.128155,"twenty":-3.128522,"median":-1.225003,"eighty":-0.37779,"marketCap":2890542},{"date":"2024-04-12","current":-0.113386,"twenty":-3.128522,"median":-1.215447,"eighty":-0.371597,"marketCap":2557418},{"date":"2024-04-19","current":-0.108126,"twenty":-3.128522,"median":-1.208193,"eighty":-0.366569,"marketCap":2438775},{"date":"2024-04-26","current":-0.093514,"twenty":-3.128522,"median":-1.197432,"eighty":-0.363688,"marketCap":2109211},{"date":"2024-05-03","current":-0.145531,"twenty":-3.128522,"median":-1.193674,"eighty":-0.361486,"marketCap":3282459},{"date":"2024-05-10","current":-0.149862,"twenty":-3.128522,"median":-1.17179,"eighty":-0.359351,"marketCap":3380128},{"date":"2024-05-17","current":-0.173835,"twenty":-3.128522,"median":-1.16293,"eighty":-0.35548,"marketCap":3424026},{"date":"2024-05-24","current":-0.152291,"twenty":-3.128522,"median":-1.149464,"eighty":-0.354774,"marketCap":2999680},{"date":"2024-05-31","current":-0.150063,"twenty":-3.128522,"median":-1.123998,"eighty":-0.350862,"marketCap":2955783},{"date":"2024-06-07","current":-0.147091,"twenty":-3.128522,"median":-1.110774,"eighty":-0.349025,"marketCap":2897252},{"date":"2024-06-14","current":-0.122576,"twenty":-3.128522,"median":-1.097551,"eighty":-0.344206,"marketCap":2414377},{"date":"2024-06-21","current":-0.122576,"twenty":-3.128522,"median":-1.084327,"eighty":-0.340305,"marketCap":2414377},{"date":"2024-06-28","current":-0.12629,"twenty":-3.132568,"median":-1.07082,"eighty":-0.338657,"marketCap":2487540},{"date":"2024-07-05","current":-0.12109,"twenty":-3.132568,"median":-1.0652,"eighty":-0.337301,"marketCap":2385112},{"date":"2024-07-12","current":-0.114404,"twenty":-3.132568,"median":-1.054404,"eighty":-0.336511,"marketCap":2253418},{"date":"2024-07-15","current":-0.122576,"twenty":-3.132568,"median":-1.054294,"eighty":-0.336109,"marketCap":2414377},{"date":"2024-08-02","current":-0.122576,"twenty":-3.145567,"median":-1.042329,"eighty":-0.334189,"marketCap":2414377},{"date":"2024-08-09","current":-0.107718,"twenty":-3.145567,"median":-1.031433,"eighty":-0.328612,"marketCap":2121725},{"date":"2024-08-16","current":-0.098061,"twenty":-3.145567,"median":-1.026043,"eighty":-0.324034,"marketCap":1931501},{"date":"2024-08-23","current":-0.135328,"twenty":-3.145567,"median":-1.010583,"eighty":-0.320046,"marketCap":2369044},{"date":"2024-08-30","current":-0.117284,"twenty":-3.145567,"median":-1.010583,"eighty":-0.317078,"marketCap":2053172},{"date":"2024-09-06","current":-0.118412,"twenty":-3.145567,"median":-1.010583,"eighty":-0.308642,"marketCap":2072914},{"date":"2024-09-13","current":-0.119539,"twenty":-3.145567,"median":-1.010583,"eighty":-0.305323,"marketCap":2092656},{"date":"2024-09-20","current":-0.115028,"twenty":-3.145567,"median":-1.000001,"eighty":-0.300543,"marketCap":2013688},{"date":"2024-09-27","current":-0.112773,"twenty":-3.145567,"median":-0.991763,"eighty":-0.290122,"marketCap":1974204},{"date":"2024-10-04","current":-0.10374,"twenty":-3.145567,"median":-0.991763,"eighty":-0.267505,"marketCap":1816070},{"date":"2024-10-11","current":-0.089677,"twenty":-3.145567,"median":-0.991763,"eighty":-0.244494,"marketCap":1569887},{"date":"2024-10-18","current":-0.113901,"twenty":-3.145567,"median":-0.991763,"eighty":-0.236178,"marketCap":1993946},{"date":"2024-10-25","current":-0.098191,"twenty":-3.145567,"median":-0.991763,"eighty":-0.210914,"marketCap":1718939},{"date":"2024-10-31","current":-0.074092,"twenty":-3.145567,"median":-0.991763,"eighty":-0.198949,"marketCap":1297052},{"date":"2024-11-08","current":-0.048007,"twenty":-3.149127,"median":-0.995882,"eighty":-0.191137,"marketCap":840418},{"date":"2024-11-15","current":-0.057811,"twenty":-3.149127,"median":-0.995882,"eighty":-0.183081,"marketCap":776454},{"date":"2024-11-22","current":-0.051049,"twenty":-3.149127,"median":-0.966785,"eighty":-0.175449,"marketCap":685641},{"date":"2024-11-29","current":-0.189585,"twenty":-3.149127,"median":-0.942175,"eighty":-0.173805,"marketCap":2546318},{"date":"2024-12-06","current":-0.190521,"twenty":-3.149127,"median":-0.915728,"eighty":-0.173805,"marketCap":2558892},{"date":"2024-12-13","current":-0.171329,"twenty":-3.149127,"median":-0.889483,"eighty":-0.17355,"marketCap":2301117},{"date":"2024-12-20","current":-0.154945,"twenty":-3.149127,"median":-0.877023,"eighty":-0.170409,"marketCap":2081064},{"date":"2024-12-27","current":-0.151809,"twenty":-3.149127,"median":-0.863936,"eighty":-0.168281,"marketCap":2038940},{"date":"2025-01-03","current":-0.173623,"twenty":-3.149127,"median":-0.84678,"eighty":-0.167056,"marketCap":2331924},{"date":"2025-01-10","current":-0.194219,"twenty":-3.152688,"median":-0.839693,"eighty":-0.167009,"marketCap":2608561},{"date":"2025-01-17","current":-0.164962,"twenty":-3.152688,"median":-0.833081,"eighty":-0.166333,"marketCap":2215611},{"date":"2025-01-24","current":-0.163839,"twenty":-3.152688,"median":-0.824192,"eighty":-0.165487,"marketCap":2200521},{"date":"2025-01-31","current":-0.167771,"twenty":-3.152688,"median":-0.812769,"eighty":-0.165487,"marketCap":2253334},{"date":"2025-02-07","current":-0.154196,"twenty":-3.152688,"median":-0.79341,"eighty":-0.163277,"marketCap":2071005},{"date":"2025-02-14","current":-0.153541,"twenty":-3.152688,"median":-0.790803,"eighty":-0.161156,"marketCap":2062203},{"date":"2025-02-21","current":-0.161966,"twenty":-3.152688,"median":-0.775769,"eighty":-0.161156,"marketCap":2175372},{"date":"2025-02-28","current":-0.172686,"twenty":-3.152688,"median":-0.757933,"eighty":-0.16016,"marketCap":2319349},{"date":"2025-03-07","current":-6.053011,"twenty":-3.195948,"median":-0.753276,"eighty":-0.16001,"marketCap":81297997},{"date":"2025-03-14","current":-5.568771,"twenty":-3.232483,"median":-0.753276,"eighty":-0.16001,"marketCap":74794157},{"date":"2025-03-21","current":-5.495401,"twenty":-3.274161,"median":-0.75374,"eighty":-0.16001,"marketCap":73808727},{"date":"2025-03-28","current":-5.609124,"twenty":-3.31057,"median":-0.754893,"eighty":-0.16001,"marketCap":75336144},{"date":"2025-04-04","current":-5.053714,"twenty":-3.323576,"median":-0.754893,"eighty":-0.16001,"marketCap":56662240},{"date":"2025-04-11","current":-4.105305,"twenty":-3.3648,"median":-0.756046,"eighty":-0.16016,"marketCap":46028678},{"date":"2025-04-17","current":-4.001748,"twenty":-3.389805,"median":-0.757933,"eighty":-0.16016,"marketCap":44867594},{"date":"2025-04-25","current":-4.234751,"twenty":-3.422243,"median":-0.765907,"eighty":-0.16001,"marketCap":47480033},{"date":"2025-05-02","current":-4.521383,"twenty":-3.478027,"median":-0.765907,"eighty":-0.16001,"marketCap":50693747},{"date":"2025-05-09","current":-5.547709,"twenty":-3.534426,"median":-0.765907,"eighty":-0.16001,"marketCap":62200916},{"date":"2025-05-16","current":-3.415449,"twenty":-3.557403,"median":-0.765907,"eighty":-0.16001,"marketCap":28508752},{"date":"2025-05-23","current":-2.266616,"twenty":-3.539832,"median":-0.765907,"eighty":-0.16001,"marketCap":18919445},{"date":"2025-05-30","current":-4.269289,"twenty":-3.557403,"median":-0.765907,"eighty":-0.16001,"marketCap":35635753},{"date":"2025-06-06","current":-1.614325,"twenty":-3.58038,"median":-0.765907,"eighty":-0.16001,"marketCap":13474769},{"date":"2025-06-13","current":-0.957922,"twenty":-3.58038,"median":-0.760277,"eighty":-0.16001,"marketCap":7995772},{"date":"2025-06-20","current":-0.900553,"twenty":-3.581732,"median":-0.757933,"eighty":-0.15986,"marketCap":7516916},{"date":"2025-06-27","current":-0.933373,"twenty":-3.581732,"median":-0.757933,"eighty":-0.15986,"marketCap":7790866},{"date":"2025-07-03","current":-0.671767,"twenty":-3.581732,"median":-0.756046,"eighty":-0.15986,"marketCap":5607236},{"date":"2025-07-11","current":-0.797011,"twenty":-3.581732,"median":-0.747691,"eighty":-0.15986,"marketCap":6652653},{"date":"2025-07-18","current":-1.561762,"twenty":-3.581732,"median":-0.742766,"eighty":-0.15986,"marketCap":13036031},{"date":"2025-07-25","current":-3.254463,"twenty":-3.581732,"median":-0.742766,"eighty":-0.15986,"marketCap":27164999},{"date":"2025-08-01","current":-2.127261,"twenty":-3.581732,"median":-0.742766,"eighty":-0.15986,"marketCap":17756247},{"date":"2025-08-08","current":-1.702188,"twenty":-3.581732,"median":-0.742766,"eighty":-0.15986,"marketCap":14208166},{"date":"2025-08-15","current":-2.197479,"twenty":-3.581732,"median":-0.742766,"eighty":-0.15986,"marketCap":14081448},{"date":"2025-08-22","current":-2.795236,"twenty":-3.581732,"median":-0.742766,"eighty":-0.15986,"marketCap":17911872},{"date":"2025-08-29","current":-2.732343,"twenty":-3.581732,"median":-0.742766,"eighty":-0.15986,"marketCap":17508854}],"updateTime":1756660121455},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CYCC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562080053","title":"Cyclacel Pharmaceuticals Dismisses Bush & Associates, Appoints SFAI as New Auditor Amid Financial Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2562080053","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562080053?lang=en_us&edition=fundamental","pubTime":"2025-08-28 18:12","pubTimestamp":1756375976,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals Inc. announced a change in its independent registered public accounting firm. Effective August 22, 2025, the company's Audit Committee approved the dismissal of Bush & Associates CPA LLP, following the firm's advisory that Cyclacel does not currently have sufficient funds to complete its development and commercialization efforts, raising substantial doubt about the company's ability to continue operations. No disagreements were noted between Cyclacel and Bush regarding accounting principles or practices. The company has engaged SFAI Malaysia PLT as its new auditor, effective August 23, 2025. Cyclacel has authorized Bush to respond fully to SFAI's inquiries regarding the situation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDLbdnbJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCC","BK4139"],"gpt_icon":0},{"id":"2559981348","title":"Cyclacel Pharmaceuticals Q2 EPS $(0.98) Up From $(10.80) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2559981348","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559981348?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:26","pubTimestamp":1755116784,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals Q2 EPS $(0.98) Up From $(10.80) YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47106911/cyclacel-pharmaceuticals-q2-eps-0-98-up-from-10-80-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cyclacel Pharmaceuticals Q2 EPS $(0.98) Up From $(10.80) YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCC"],"gpt_icon":0},{"id":"2559063386","title":"Cyclacel Pharmaceuticals Reports Zero Revenue, Operating Loss of $5.04M for Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559063386","media":"Reuters","labels":["shareholding","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559063386?lang=en_us&edition=fundamental","pubTime":"2025-08-13 18:21","pubTimestamp":1755080484,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals Inc. has released its financial results for the three months ended March 31, 2025. The company reported no revenue from clinical trial supply for the period, compared to $29,000 in the same period in 2024. Operating expenses increased to $5.036 million from $4.384 million in the previous year, driven by research and development expenses of $822,000 and general and administrative expenses of $4.214 million. The company incurred an operating loss of $5.036 million, compared to a loss of $4.355 million in the same period last year. Notably, Cyclacel recorded a gain of $4.947 million from the deconsolidation of a subsidiary. The company is focused on its clinical-stage biopharmaceutical operations, developing innovative cancer medicines targeting cell cycle, transcriptional regulation, epigenetics, and mitosis control biology. No guidance or outlook was provided.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL7v8lQ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCC"],"gpt_icon":0},{"id":"2557198337","title":"David E. Lazar, 10% Owner, Reports Disposal of Common Shares of Cyclacel Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2557198337","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557198337?lang=en_us&edition=fundamental","pubTime":"2025-08-05 07:23","pubTimestamp":1754349814,"startTime":"0","endTime":"0","summary":"David E. Lazar, a 10% owner of Cyclacel Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclacel Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDLBDrLc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CYCC"],"gpt_icon":0},{"id":"2557337530","title":"CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB","url":"https://stock-news.laohu8.com/highlight/detail?id=2557337530","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557337530?lang=en_us&edition=fundamental","pubTime":"2025-08-05 06:50","pubTimestamp":1754347800,"startTime":"0","endTime":"0","summary":"- Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA LUMPUR, Malaysia, Aug.  04, 2025  (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/04/3126990/0/en/CYCLACEL-PHARMACEUTICALS-HIGHLIGHTS-PRECLINICAL-DATA-SHOWING-THAT-CANCER-OF-THE-BILIARY-TRACT-IS-SENSITIVE-TO-PLOGOSERTIB.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4097","BTC","IS","CYCCP","CYCC"],"gpt_icon":0},{"id":"2555709124","title":"Cyclacel Pharmaceuticals Removes Series F Ownership Limitation in Bylaws Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=2555709124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555709124?lang=en_us&edition=fundamental","pubTime":"2025-07-29 04:07","pubTimestamp":1753733239,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals Inc. has announced amendments to its bylaws, specifically concerning its Series F Convertible Preferred Stock. As of July 28, 2025, the company has filed an Amended and Restated Certificate of Designations with the State of Delaware, which became effective immediately. The primary change involves the removal of the Series F Ownership Limitation, allowing the shares to be converted and voted without previous restrictions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclacel Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 28, 2025, and i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nNDLbmhgl7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCC","BK4139"],"gpt_icon":0},{"id":"2552966424","title":"Cyclacel Pharmaceuticals trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2552966424","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552966424?lang=en_us&edition=fundamental","pubTime":"2025-07-18 22:55","pubTimestamp":1752850527,"startTime":"0","endTime":"0","summary":"10:52 EDT Cyclacel Pharmaceuticals (CYCC) trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cyclacel-pharmaceuticals-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cyclacel-pharmaceuticals-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CYCC"],"gpt_icon":0},{"id":"2551123251","title":"CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY","url":"https://stock-news.laohu8.com/highlight/detail?id=2551123251","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551123251?lang=en_us&edition=fundamental","pubTime":"2025-07-16 21:00","pubTimestamp":1752670800,"startTime":"0","endTime":"0","summary":"Kuala Lumpur, Malaysia, July  16, 2025  (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/16/3116470/0/en/CYCLACEL-PHARMACEUTICALS-COMMENTS-ON-RECENT-STOCK-PRICE-VOLATILITY.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4512","BK4585","LU1861220033.SGD","BK4141","ON","LU0348723411.USD","LU1861214812.USD","LU1854103824.USD","LU1978683503.SGD","IE00BZ199S13.USD","LU1861215975.USD","CYCC","BK4139","LU1720051017.SGD","CYCCP","LU1548497426.USD","LU1854104046.USD","LU0124384867.USD","LU0724618433.USD","BK4588","BK4605","LU1861219969.SGD","LU2360107325.USD","LU2298322129.HKD","LU1720051108.HKD","IE00BD6J9T35.USD","LU2357305700.SGD"],"gpt_icon":1},{"id":"2549638925","title":"Cyclacel Pharmaceuticals Secures $3 Million in Series F Preferred Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2549638925","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549638925?lang=en_us&edition=fundamental","pubTime":"2025-07-08 05:44","pubTimestamp":1751924697,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals, Inc., a Delaware corporation, has announced that a stockholder holding a majority of the company's voting power has taken decisive action through written consent. This stockholder, possessing approximately 51.2% of the total voting power, has executed decisions that are pivotal for the company's strategic direction. The company, based in Kuala Lumpur, Malaysia, remains committed to keeping its stakeholders informed about significant corporate actions and developments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclacel Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nNDLClPg1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CYCC"],"gpt_icon":0},{"id":"2549315535","title":"Cyclacel announces amendment to exchange agreement with Fitters","url":"https://stock-news.laohu8.com/highlight/detail?id=2549315535","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549315535?lang=en_us&edition=fundamental","pubTime":"2025-07-07 18:12","pubTimestamp":1751883147,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals (CYCC) has entered into an amendment to the Exchange Agreement with FITTERS Diversified Berhad. Pursuant to the Exchange A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cyclacel-announces-amendment-to-exchange-agreement-with-fitters-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cyclacel-announces-amendment-to-exchange-agreement-with-fitters-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CYCC"],"gpt_icon":0},{"id":"2549533692","title":"CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER","url":"https://stock-news.laohu8.com/highlight/detail?id=2549533692","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549533692?lang=en_us&edition=fundamental","pubTime":"2025-07-07 18:00","pubTimestamp":1751882400,"startTime":"0","endTime":"0","summary":"- Fibrolamellar hepatocellular carcinoma (FLC) has no approved treatment and occurs mostly in adolescents and young adults - KUALA LUMPUR, Malaysia, July  07, 2025  (GLOBE NEWSWIRE) -- Cyclacel Pharma","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/07/3110860/0/en/CYCLACEL-PHARMACEUTICALS-HIGHLIGHTS-PUBLICATION-OF-PRECLINICAL-DATA-SHOWING-THAT-PLOGOSERTIB-IS-ACTIVE-IN-A-HARD-TO-TREAT-SUBTYPE-OF-LIVER-CANCER.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCCP","BK4211","FLC","HARD","IS","CYCC","FCF","BK4139","BK4097"],"gpt_icon":0},{"id":"2549336035","title":"CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT","url":"https://stock-news.laohu8.com/highlight/detail?id=2549336035","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549336035?lang=en_us&edition=fundamental","pubTime":"2025-07-07 18:00","pubTimestamp":1751882400,"startTime":"0","endTime":"0","summary":"Kuala Lumpur, Malaysia, July  07, 2025  (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/07/3110861/0/en/CYCLACEL-PHARMACEUTICALS-ANNOUNCES-AMENDMENT-TO-EXCHANGE-AGREEMENT.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCCP","BK4139","CYCC"],"gpt_icon":0},{"id":"2548380805","title":"Cyclacel Pharmaceuticals trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2548380805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548380805?lang=en_us&edition=fundamental","pubTime":"2025-07-04 04:55","pubTimestamp":1751576121,"startTime":"0","endTime":"0","summary":"16:50 EDT Cyclacel Pharmaceuticals (CYCC) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cyclacel-pharmaceuticals-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cyclacel-pharmaceuticals-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CYCC"],"gpt_icon":0},{"id":"2548897862","title":"Cyclacel Pharmaceuticals Announces 1-for-15 Reverse Stock Split Effective July 7, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2548897862","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548897862?lang=en_us&edition=fundamental","pubTime":"2025-07-02 21:01","pubTimestamp":1751461262,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals Inc. has announced a 1-for-15 reverse stock split, set to take effect on July 7, 2025. The company's shares will trade on a split-adjusted basis under the symbol \"CYCC\" on the Nasdaq Capital Market. Following the reverse split, the number of outstanding shares will reduce from 23,759,475 to 1,583,965. No fractional shares will be issued, with fractional shares rounded to the nearest whole number.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclacel Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 02, 2025, and is solely responsible for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL4zFpWq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CYCC"],"gpt_icon":0},{"id":"2548010457","title":"Cyclacel Pharmaceuticals Inc. Concluded Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2548010457","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548010457?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:29","pubTimestamp":1751315349,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals Inc. held its 2025 Annual Meeting on June 30. Shareholders re-elected five directors. An amendment to the 2018 Equity Incentive Plan, increasing the number of shares available for awards, was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclacel Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 30, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL2ZWStp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CYCC"],"gpt_icon":0},{"id":"2546240911","title":"Cyclacel Pharmaceuticals Secures $3 Million Through Preferred Stock Agreement with Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2546240911","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546240911?lang=en_us&edition=fundamental","pubTime":"2025-06-26 01:31","pubTimestamp":1750872717,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals, Inc., based in Kuala Lumpur, Malaysia, has announced that a stockholder holding a majority of the company's voting power has taken action by written consent. This decision involves 12,164,301 shares of common stock, representing approximately 51.2% of the total voting power. The action, taken on June 18, 2025, allows the company to proceed with certain corporate matters without the need for a special meeting of stockholders. Cyclacel Pharmaceuticals continues its commitment to advancing its corporate objectives with this strategic move.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclacel Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gath","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL1qbRyY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CYCC"],"gpt_icon":0},{"id":"2545700201","title":"Press Release: Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2545700201","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545700201?lang=en_us&edition=fundamental","pubTime":"2025-06-21 04:30","pubTimestamp":1750451400,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, June 20, 2025  -- Cyclacel Pharmaceuticals, Inc.  , a biopharmaceutical company that develops innovative cancer medicine, today announced that it has entered into a securities purchase agreement for the sale of its convertible Series F Preferred Stock  in a private placement to certain accredited investors yielding gross proceeds of $3.0 million before deducting offering expenses. In connection with the offering, Cyclacel issued to each investor, a series A common stock purchase warrant to purchase 3,270,000 shares of the Company's common stock, par value $0.001 per share  at an exercise price of $0.51 per share, series B common stock purchase warrant to purchase 3,270,000 shares of Common Stock at an exercise price of $0.60 per share and series C common stock purchase warrant to purchase 3,270,000 shares of Common Stock at an exercise price of $0.68 per share . The Warrants expire five years from the date of issuance. The offering closed on June 20, 2025.Arc Group Ltd. s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":0},{"id":"2540570739","title":"Cyclacel Pharmaceuticals Inc. Declares Quarterly Cash Dividend of $0.15 Per Share on Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2540570739","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540570739?lang=en_us&edition=fundamental","pubTime":"2025-06-04 05:00","pubTimestamp":1748984446,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals Inc. has announced a quarterly cash dividend of $0.15 per share for its 6% Convertible Exchangeable Preferred Stock. This dividend is scheduled for payment on August 1, 2025, to stockholders who are recorded as of July 21, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclacel Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL1JpHVp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCC","BK4139"],"gpt_icon":0},{"id":"2540704791","title":"Cyclacel Pharmaceuticals Regains Nasdaq Compliance After Meeting Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2540704791","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540704791?lang=en_us&edition=fundamental","pubTime":"2025-06-04 04:16","pubTimestamp":1748981767,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals Inc. has announced that it has regained compliance with the Nasdaq Stock Market's Minimum Bid Price Requirement. The biopharmaceutical company, known for developing innovative cancer medicines, received a Compliance Notice from Nasdaq on June 3, 2025, confirming that the company has met the necessary criteria. Previously, on December 6, 2024, Cyclacel was notified that its shares had failed to maintain the minimum bid price of $1.00 for 30 consecutive business days. However, from May 12 to June 2, 2025, the closing bid price of Cyclacel's shares consistently exceeded $1.00, enabling the company to meet the requirement and resolve the issue.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclacel Pharmaceuticals","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDLyktcg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCC","BK4139"],"gpt_icon":0},{"id":"2537319157","title":"Cyclacel Pharmaceuticals Approves Reverse Stock Split Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=2537319157","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537319157?lang=en_us&edition=fundamental","pubTime":"2025-05-24 05:04","pubTimestamp":1748034248,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals, Inc.'s board of directors has announced recent actions taken with the approval of the majority stockholder. The company, based in Kuala Lumpur, Malaysia, is undergoing changes as detailed in a third amendment to its amended and restated certificate of incorporation. The amendment was certified on May 23, 2025, with Datuk Dr. Doris Wong Sing Ee, the Chief Executive Officer and Executive Director, affirming the decisions made. Further developments and the implications of these actions are expected to be significant for the company's strategic direction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclacel Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Elect","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL6mV8Ws:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCC","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}]}}